These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 8381011

  • 41. Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys.
    Negus SS, Brandt MR, Mello NK.
    J Pharmacol Exp Ther; 1999 Oct; 291(1):60-9. PubMed ID: 10490887
    [Abstract] [Full Text] [Related]

  • 42. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE, Bigelow GE, Preston KL.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Butorphanol and nalbuphine: a pharmacologic comparison.
    Pallasch TJ, Gill CJ.
    Oral Surg Oral Med Oral Pathol; 1985 Jan; 59(1):15-20. PubMed ID: 2983281
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception.
    Fischer BD, Dykstra LA.
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1300-6. PubMed ID: 16772537
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Drug discrimination in human postaddicts: agonist-antagonist opioids.
    Preston KL, Bigelow GE, Bickel WK, Liebson IA.
    J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Self-administration of nalbuphine, butorphanol and pentazocine by morphine post-addict rats.
    Steinfels GF, Young GA, Khazan N.
    Pharmacol Biochem Behav; 1982 Jan; 16(1):167-71. PubMed ID: 7199184
    [Abstract] [Full Text] [Related]

  • 51. The GABAB agonist baclofen modifies cocaine self-administration in rats.
    Shoaib M, Swanner LS, Beyer CE, Goldberg SR, Schindler CW.
    Behav Pharmacol; 1998 May; 9(3):195-206. PubMed ID: 9832934
    [Abstract] [Full Text] [Related]

  • 52. Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure.
    Oliveto A, Sevarino K, McCance-Katz E, Feingold A.
    Pharmacol Biochem Behav; 2002 May; 71(1-2):85-96. PubMed ID: 11812511
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Nalbuphine and butorphanol reverse opioid-induced respiratory depression but increase arousal in etorphine-immobilized goats (Capra hircus).
    Haw AJ, Meyer LC, Fuller A.
    Vet Anaesth Analg; 2016 Sep; 43(5):539-48. PubMed ID: 26878827
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeys.
    John WS, Newman AH, Nader MA.
    Neuropharmacology; 2015 May; 92():34-43. PubMed ID: 25576373
    [Abstract] [Full Text] [Related]

  • 60. Double-blind comparison of butorphanol and nalbuphine on the common bile duct by ultrasonography in man.
    Vieira ZE, Zsigmond EK, Duarte B, Renigers SA, Hirota K.
    Int J Clin Pharmacol Ther Toxicol; 1993 Nov; 31(11):564-7. PubMed ID: 8294171
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.